Dennis Falzon

Summary

Affiliation: World Health Organization
Country: Switzerland

Publications

  1. ncbi Giving a voice to those who die young: the fatal impact of tuberculosis and HIV in South Africa
    Dennis Falzon
    Stop TB Department, World Health Organization, Geneva, Switzerland
    Future Microbiol 5:1641-3. 2010
  2. ncbi WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
    D Falzon
    Stop TB Dept, World Health Organization, Geneva 27, Switzerland
    Eur Respir J 38:516-28. 2011
  3. ncbi Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010
    Matteo Zignol
    Stop TB Department, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland
    Bull World Health Organ 90:111-119D. 2012
  4. ncbi Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance
    Abigail Wright
    Stop TB Department, WHO, Geneva, Switzerland
    Lancet 373:1861-73. 2009
  5. ncbi Global epidemiology of tuberculosis
    Philippe Glaziou
    Stop TB Department STB, HIV AIDS, TB, Malaria and Neglected Tropical Diseases Cluster HTM, World Health Organization, Geneva, Switzerland
    Semin Respir Crit Care Med 34:3-16. 2013
  6. ncbi WHO guidance on electronic systems to manage data for tuberculosis care and control
    Hazim Timimi
    Stop TB Department, World Health Organization, Geneva, Switzerland
    J Am Med Inform Assoc 19:939-41. 2012
  7. ncbi Modernizing surveillance of antituberculosis drug resistance: from special surveys to routine testing
    Matteo Zignol
    Stop TB Department, World Health Organization, Geneva, Switzerland
    Clin Infect Dis 52:901-6. 2011

Detail Information

Publications7

  1. ncbi Giving a voice to those who die young: the fatal impact of tuberculosis and HIV in South Africa
    Dennis Falzon
    Stop TB Department, World Health Organization, Geneva, Switzerland
    Future Microbiol 5:1641-3. 2010
    ..The investigative methodology used by the authors could be more widely applied to advocate for lifesaving measures in other settings sharing similar epidemiological challenges...
  2. ncbi WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
    D Falzon
    Stop TB Dept, World Health Organization, Geneva 27, Switzerland
    Eur Respir J 38:516-28. 2011
    ..Controlled trials are needed to improve the quality of existing evidence, particularly on the optimal composition and duration of MDR-TB treatment regimens...
  3. ncbi Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010
    Matteo Zignol
    Stop TB Department, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland
    Bull World Health Organ 90:111-119D. 2012
    ..To present a global update of drug-resistant tuberculosis (TB) and explore trends in 1994-2010...
  4. ncbi Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance
    Abigail Wright
    Stop TB Department, WHO, Geneva, Switzerland
    Lancet 373:1861-73. 2009
    ..The Global Project on Anti-Tuberculosis Drug Resistance has been gathering data since 1994. This study provides the latest data on the extent of drug resistance worldwide...
  5. ncbi Global epidemiology of tuberculosis
    Philippe Glaziou
    Stop TB Department STB, HIV AIDS, TB, Malaria and Neglected Tropical Diseases Cluster HTM, World Health Organization, Geneva, Switzerland
    Semin Respir Crit Care Med 34:3-16. 2013
    ....
  6. ncbi WHO guidance on electronic systems to manage data for tuberculosis care and control
    Hazim Timimi
    Stop TB Department, World Health Organization, Geneva, Switzerland
    J Am Med Inform Assoc 19:939-41. 2012
    ..The guide uses examples from eHealth projects recently implemented in Brazil, China, Pakistan and other settings to illustrate how projects in diverse settings have overcome different challenges...
  7. ncbi Modernizing surveillance of antituberculosis drug resistance: from special surveys to routine testing
    Matteo Zignol
    Stop TB Department, World Health Organization, Geneva, Switzerland
    Clin Infect Dis 52:901-6. 2011
    ..Routine surveillance linked to patient care, which represents the best approach to monitor drug resistance, now has the possibility of becoming a reality even in resource-limited countries...